Our Products

AUBAGIO
teriflunomide

Prescribing Information GB
Prescribing Information NI

MAT-XU-2200676 (v2.0)
Date of preparation: August 2022

FABRAZYME
agalsidase beta

Prescribing Information UK

MAT-GB-2105812 (v2.0)
Date of preparation: August 2022

LANTUS
insulin glargine

Prescribing Information UK

MAT-XU-2201444 (v2.0)
Date of preparation: August 2022

LEMTRADA
Alemtuzumab

Prescribing Information GB
Prescribing Information NI

MAT-XU-2200680 (v2.0)
Date of preparation: August 2022

MYOZYME
alglucosidase alfa

Prescribing Information UK

MAT-GB-2105179 (v2.0)
Date of preparation: August 2022

TOUJEO
insulin glargine

Prescribing Information UK

MAT-GB-2105435 (v2.0)
Date of preparation: August 2022

▼ This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.

MAT-GB-2105466 (v1.0)
Date of preparation: February 2022